Distinct pulmonary patterns in ANCA-associated vasculitides: insights from a retrospective single center cohort study

Jennette JC, Falk RJ, Andrassy K et al (1994) Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37:187–192. https://doi.org/10.1002/art.1780370206

Article  CAS  PubMed  Google Scholar 

Radice A, Sinico RA (2005) Antineutrophil cytoplasmic antibodies (ANCA). Autoimmunity 38:93–103. https://doi.org/10.1080/08916930400022673

Article  CAS  PubMed  Google Scholar 

Falde SD, Fussner LA, Tazelaar HD et al (2024) Proteinase 3-specific antineutrophil cytoplasmic antibody-associated vasculitis. Lancet Rheumatol 6:e314–e327. https://doi.org/10.1016/S2665-9913(24)00035-3

Article  CAS  PubMed  Google Scholar 

Arnold S, Kitching AR, Witko-Sarsat V et al (2024) Myeloperoxidase-specific antineutrophil cytoplasmic antibody-associated vasculitis. Lancet Rheumatol 6:e300–e313. https://doi.org/10.1016/S2665-9913(24)00025-0

Article  CAS  PubMed  Google Scholar 

Anderson G, Coles ET, Crane M et al (1992) Wegener’s granuloma. A series of 265 British cases seen between 1975 and 1985. A report by a sub-committee of the British Thoracic Society Research Committee. Q J Med 83:427–438

CAS  PubMed  Google Scholar 

Comarmond C, Cacoub P (2014) Granulomatosis with polyangiitis (Wegener): clinical aspects and treatment. Autoimmun Rev 13:1121–1125. https://doi.org/10.1016/j.autrev.2014.08.017

Article  PubMed  Google Scholar 

Schirmer JH, Wright MN, Vonthein R et al (2016) Clinical presentation and long-term outcome of 144 patients with microscopic polyangiitis in a monocentric German cohort. Rheumatology (Oxford) 55:71–79. https://doi.org/10.1093/rheumatology/kev286

Article  PubMed  Google Scholar 

Guillevin L, Durand-Gasselin B, Cevallos R et al (1999) Microscopic polyangiitis: Clinical and laboratory findings in eighty-five patients. Arthritis Rheum 42:421–430. https://doi.org/10.1002/1529-0131(199904)42:3%3c421::AID-ANR5%3e3.0.CO;2-6

Article  CAS  PubMed  Google Scholar 

Robson JC, Grayson PC, Ponte C et al (2022) 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis. Ann Rheum Dis 81:315–320. https://doi.org/10.1136/annrheumdis-2021-221795

Article  PubMed  Google Scholar 

Suppiah R, Robson JC, Grayson PC et al (2022) 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Microscopic Polyangiitis. Arthritis Rheumatol 74:400–406. https://doi.org/10.1002/art.41983

Article  CAS  PubMed  Google Scholar 

Ambrogi E, Cavazza A, Smith ML, Graziano P (2024) Pulmonary pathology in vasculitis. Pathologica 116:93–103. https://doi.org/10.32074/1591-951X-988

Hellmich B, Sanchez-Alamo B, Schirmer JH et al (2023) EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update. Ann Rheum Dis. https://doi.org/10.1136/ard-2022-223764

Article  Google Scholar 

Jayne DRW, Merkel PA, Schall TJ, Bekker P (2021) Avacopan for the treatment of ANCA-associated vasculitis. N Engl J Med 384:599–609. https://doi.org/10.1056/NEJMoa2023386

Article  CAS  PubMed  Google Scholar 

Luqmani RA, Bacon PA, Moots RJ et al (1994) Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM 87:671–678

CAS  PubMed  Google Scholar 

Exley AR, Bacon PA, Luqmani RA et al (1997) Development and initial validation of the vasculitis damage index for the standardized clinical assessment of damage in the systemic vasculitides. Arthritis Rheum 40:371–380. https://doi.org/10.1002/art.1780400222

Article  CAS  PubMed  Google Scholar 

Diagnostics | Free Full-Text | Pulmonary Vasculitides: A Radiological Review Emphasizing Parenchymal HRCT Features. https://www.mdpi.com/2075-4418/11/12/2318. Accessed 17 Jun 2024

Mohammad AJ, Mortensen KH, Babar J et al (2017) Pulmonary involvement in antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: The influence of ANCA subtype. J Rheumatol 44:1458–1467. https://doi.org/10.3899/jrheum.161224

Article  PubMed  Google Scholar 

Suzuki A, Sakamoto S, Kurosaki A et al (2019) Chest high-resolution CT findings of microscopic polyangiitis: a Japanese first Nationwide prospective Cohort Study. Am J Roentgenol 213:104–114. https://doi.org/10.2214/AJR.18.20967

Article  Google Scholar 

Tzelepis GE, Kokosi M, Tzioufas A et al (2010) Prevalence and outcome of pulmonary fibrosis in microscopic polyangiitis. Eur Respir J 36:116–121. https://doi.org/10.1183/09031936.00110109

Article  CAS  PubMed  Google Scholar 

Cozzi D, Cavigli E, Moroni C et al (2021) Ground-glass opacity (GGO): a review of the differential diagnosis in the era of COVID-19. Jpn J Radiol 39:721–732. https://doi.org/10.1007/s11604-021-01120-w

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kida T, Tanaka T, Yokota I et al (2020) Association between preexisting lung involvements and the risk of diffuse alveolar hemorrhage in patients with microscopic polyangiitis: A multi-center retrospective cohort study. Mod Rheumatol 30:338–344. https://doi.org/10.1080/14397595.2019.1601855

Article  PubMed  Google Scholar 

Hogan SL, Nachman PH, Wilkman AS et al (1996) Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol 7:23. https://doi.org/10.1681/ASN.V7123

Article  CAS  PubMed  Google Scholar 

Pagnoux C, Hogan SL, Chin H et al (2008) Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis. Arthritis Rheum 58:2908–2918. https://doi.org/10.1002/art.23800

Article  PubMed  PubMed Central  Google Scholar 

Hogan SL, Falk RJ, Chin H et al (2005) Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis. Ann Intern Med 143:621–631. https://doi.org/10.7326/0003-4819-143-9-200511010-00005

Article  PubMed  Google Scholar 

Walsh M, Flossmann O, Berden A et al (2012) Risk factors for relapse of antineutrophil cytoplasmic antibody–associated vasculitis. Arthritis Rheum 64:542–548. https://doi.org/10.1002/art.33361

Article  CAS  PubMed  Google Scholar 

Salmela A, Törnroth T, Poussa T, Ekstrand A (2018) Prognostic factors for survival and relapse in ANCA-associated vasculitis with renal involvement: a clinical long-term follow-up study. Int J Nephrol. https://doi.org/10.1155/2018/6369814

Article  PubMed  PubMed Central  Google Scholar 

Seo P, Min Y-I, Holbrook JT et al (2005) Damage caused by Wegener’s granulomatosis and its treatment: Prospective data from the Wegener’s Granulomatosis Etanercept Trial (WGET). Arthritis Rheum 52:2168–2178. https://doi.org/10.1002/art.21117

Article  CAS  PubMed  Google Scholar 

Koldingsnes W, Nossent H (2002) Predictors of survival and organ damage in Wegener’s granulomatosis. Rheumatology 41:572–581. https://doi.org/10.1093/rheumatology/41.5.572

Article  CAS  PubMed  Google Scholar 

Russell B, Mohan S, Chahal R et al (2018) Prognostic significance of cavitary lung nodules in granulomatosis with polyangiitis (Wegener’s): a clinical imaging study of 225 patients. Arthritis Care Res (Hoboken) 70:1082–1089. https://doi.org/10.1002/acr.23443

Article  PubMed  Google Scholar 

Alba MA, Flores-Suárez LF, Henderson AG et al (2017) Interstital lung disease in ANCA vasculitis. Autoimmun Rev 16:722–729. https://doi.org/10.1016/j.autrev.2017.05.008

Article  PubMed  PubMed Central  Google Scholar 

Borie R, Crestani B (2018) Antineutrophil cytoplasmic antibody-associated lung fibrosis. Semin Respir Crit Care Med 39:465–470. https://doi.org/10.1055/s-0038-1669914

Article  PubMed  Google Scholar 

Hozumi H, Oyama Y, Yasui H et al (2018) Clinical significance of myeloperoxidase-anti-neutrophil cytoplasmic antibody in idiopathic interstitial pneumonias. PLoS One 13:e0199659.

Comments (0)

No login
gif